Current evidence for molecular and cellular mechanisms underlying neuroblastoma initiation, progression, and therapeutic resistance is examined, with a focus on MYCN amplification, ALK pathway dysregulation, chromosomal instability, telomere maintenance mechanisms, epigenetic remodeling, and neural crest developmental...
Amitabh Singh, Neha Goel, S. Mehndiratta et al.· Frontiers in Oncology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.